Exploratory Analyses of Progression-Free Survival (PFS) with Lenalidomide-Bortezomib-Dexamethasone (RVd) Alone/RVd+ASCT by Duffy genotype in Patients (pts) with Newly Diagnosed Multiple Myeloma (NDMM)
Year: 2025
Type: article
Authors: Lauren Merz, Rebecca Zon, Susanna Jacobus, Mehmet Samur, Jeffrey Zonder, Abdullah Khan, Hani Hassoun, Larry Anderson, Yvonne Efebera, Tondre T. Buck, Racquel Innis Shelton, Monique Hartley-Brown, Sagar Lonial, Erica Campagnaro, Peter Voorhees, Robert Orlowski, Noopur Raje, Philip McCarthy, Jacob Laubach, Omar Nadeem, Irene Ghobrial, Clifton Mo, Kenneth Anderson, Nikhil Munshi, Paul Richardson
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414303451
FWCI:
Cites:
Cited by:
Related to: